Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults

NCT02100917 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: DMB-3111
DRUG: trastuzumab

Sponsor

Meiji Seika Pharma Co., Ltd.

Collaborators

[object Object]